MO

Motus GI Holdings IncOOTC MOTS Stock Report

Last reporting period 31 Mar, 2024

Updated 15 Nov, 2024

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

MOTS Stock Analysis

MO

Uncovered

Motus GI Holdings Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-23/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

4.656 B

Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 30 full-time employees. The company went IPO on 2018-02-14. The Company, through its subsidiaries in the United States and Israel, is engaged in providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions. The company has developed the Pure-Vu System, a medical device that helps to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. Its wholly owned subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.

View Section: Eyestock Rating